The following acquisitions have positioned Stryker to lead the way to better healthcare delivery, patient experiences and clinical performance.


Specializing in support surface and pressure ulcer management solutions, as well as products for the temperature management segment of the healthcare industry, Gaymar has been our Medical division’s primary supplier of high-end surfaces for the past 10 years. As part of our company, Gaymar will help introduce us to new markets that yield innovative technologies and growth opportunities.


The acquisition of the assets of Boston Scientific’s Neurovascular division will position us to be a leader in the neurovascular market, one of the fastest-growing and most innovative sectors in medical technology. Neurovascular’s products have the potential to save lives by addressing the need for ischemic stroke treatment devices.


These implantable porous polyethylene products used in reconstructive surgery of the face, eye, and head further expand our presence in the craniomaxillofacial (CMF) and oculoplastic markets and allow us to broaden our product offerings to both patients and clinicians.


The Ascent acquisition enables Stryker to provide reprocessing and remanufacturing services to hospitals and surgery centers, offering a greener, more cost effective alternative. In addition to saving hospitals hundreds of thousands of dollars, reprocessing eliminates millions of pounds of medical waste every year that would otherwise have entered local landfills.


With the Sonopet Ultrasonic Aspirator, neurosurgeons are able to effectively address fine bone dissection as well as soft tissue removal. This greatly extends surgeons’ capabilities and enables them to deliver better clinical outcomes.